EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru

Salyoc Tapia-Rojas, Alexis Germán Murillo Carrasco, Maria J Pons, Manuel Ugarte-Gil, Ana Mayanga-Herrera

PeerJ · 2025

DOI: 10.7717/peerj.19771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Salyoc Tapia-Rojas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Stem Cells Research Group, Universidad Cientifica del Sur, Lima, Peru. Hauptthemen laut MEDLINE: COVID-19, Immunoglobulin M, Immunoglobulin G, Antibodies, Viral. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The “Semilla COVID-19” grant given by Universidad Científica del Sur, “Kaelin Prize 2020” from EsSalud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic exposed vulnerabilities in health systems and revealed variations in immune responses across populations worldwide. This study examined the kinetics of IgG and IgM antibodies against S1 and receptor-binding domain (RBD) proteins in hospitalized Peruvian patients prior to vaccination.

Method

A total of 157 serological samples were collected from 44 hospitalized COVID-19 patients during Peru’s first wave (August–October 2020) and stored at −80 °C. Anti-SARS-CoV-2 IgG and IgM antibodies were quantified using an in-house ELISA with recombinant Spike S1 and RBD proteins. Statistical analyses—including linear regression, Kaplan-Meier curves, and receiver operating characteristic (ROC) curves—were conducted to evaluate antibody kinetics, clinical correlations, and predictive accuracy.

Results

IgG levels stabilized between days 10 and 15 of hospitalization, while IgM levels declined after day 10, with greater variability observed in severe acute respiratory distress syndrome (ARDS) cases. A significant positive correlation was found between IgG levels and lymphocyte counts ( R = 0.37, p < 0.001), and a negative correlation with neutrophil counts ( R = − 0.33, p < 0.01), particularly in severe ARDS non-ICU patients ( R = − 0.34, p < 0.01). Severe ARDS cases also exhibited elevated neutrophil-to-lymphocyte ratios and increased inflammatory biomarkers, such as C-reactive protein and D-dimer, indicating an exacerbated inflammatory response associated with poorer prognosis. Risk factors, including sex and obesity, were linked to higher mortality and increased need for mechanical ventilation. This study contributes to a better understanding of the immune response in COVID-19 and supports the development of predictive models based on immunological and hematological biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunoglobulin MImmunoglobulin GAntibodies, ViralSARS-CoV-2HumansPeruMaleFemaleMiddle AgedHospitalizationAdultAgedSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

AntibodiesCOVID-19HospitalizationImmunityKineticsPeru

Substanzen

Immunoglobulin MImmunoglobulin GAntibodies, ViralSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Cancer and Stem Cells Research Group, Universidad Cientifica del Sur, Lima, Peru.
  • Laboratorio de Cultivo Celular e Inmunologia, Universidad Cientifica del Sur, Lima, Peru.
  • Facultad de Medicina, Universidad San Martin de Porres, Lima, Peru.
  • Centro de Investigação Translacional em Oncologia (LIM24), Departamento de Radiologia, Universidade de São Paulo, Sao Paulo, Brazil.
  • Grupo de Enfermedades Infecciosas Re-Emergentes, Universidad Cientifica del Sur, Lima, Peru.
  • Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, Peru.

Förderung

  • The “Semilla COVID-19” grant given by Universidad Científica del Sur
  • “Kaelin Prize 2020” from EsSalud

Zitieren

APA

Tapia-Rojas, S., Murillo Carrasco, A. G., Pons, M. J., Ugarte-Gil, M., & Mayanga-Herrera, A. (2025). Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru. PeerJ. https://doi.org/10.7717/peerj.19771

Vancouver

Tapia-Rojas S, Murillo Carrasco AG, Pons MJ, Ugarte-Gil M, Mayanga-Herrera A. Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru. PeerJ. 2025. doi:10.7717/peerj.19771

BibTeX
@article{TapiaRojas2025,
  author = {Tapia-Rojas, Salyoc and Murillo Carrasco, Alexis Germán and Pons, Maria J and Ugarte-Gil, Manuel and Mayanga-Herrera, Ana},
  title = {Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19771}
}
Kostenlos starten →